Efficacy of Prophylactic Treatment of Oral Prochlorperazine for Acute Mountain Sickness
Status:
COMPLETED
Trial end date:
2023-03-13
Target enrollment:
Participant gender:
Summary
A field-based trial was conducted to determine if oral prochlorperazine demonstrates efficacy in the prophylactic treatment of AMS, and/or decreases the incidence of the symptoms of acute mountain sickness including headache, GI symptoms, fatigue and dizziness based on data collected in the Lake Louise AMS score.